Investing
The company plans to use the new money to invest in its data and building out its products.
An R&D cloud platform which supports scientists to share and access progress with the development of biopharmaceutical therapeutics has raised $35 million in investment capital.
This new round of funding brings the company's total raise to $51.4 million.
DrugStoc scooped up $4.4 million in funding, and African Health Holdings landed $18 million.
Pear announced plans to go public through a merger with a special purpose acquisition company in June, and the deal is set to close soon.
Also: Amwell misses revenue expectations and Babylon Health grows 371% year-over-year.
The Series B brings the company’s total raise to $71 million.
Also: Remote patient monitoring platform HealthSnap brings in $5 million, and behavioral health-focused Videra Health raises a $3 million seed round.
This new funding round brings the company's total raise to roughly $62.5 million.
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.